RELATED ARTICLES |
The company had posted a net profit of Rs 13.72 crore in the same period of the last financial year, Natco Pharma said in a filing to the BSE.
The consolidated total income during the third quarter also went up by 22.89 per cent to Rs 145.43 crore from Rs 118.34 crore in the year-ago period, it added.
The board of directors also declared an interim dividend of Rs 3 per equity share of Rs 10 each for 2011-2012.
The shares of the company today closed 1.04 per cent lower at Rs 272.20 apiece on the BSE




















Post new comment